Glenn H Cantor

age ~72

from Bend, OR

Get Report

Also known as:

Glenn Howard Cantor
Glen H Cantor

Connected to:

Glenn Cantor Phones & Addresses

Bend, OR
San Diego, CA
Worcester, MA
77 Elm Ridge Rd, Princeton, NJ 08540 • 6093339951
North Easton, MA
Trenton, NJ
Kalamazoo, MI
Pullman, WA

Work

Company:

Bristol-myers squibb
Sep 2003
Address:

Princeton, NJ
Position:

Veterinary pathology fellow

Education

Degree:

Postdoctoral
School / High School:

Washington State University
1993 to 1994
Specialities:

Dept of Biochemistry and Biophysics

Skills

Drug Discovery • Toxicology • Pathology • Biochemistry • Oncology • Life Sciences • Laboratory • Microbiology • In Vivo • Veterinary Medicine • Biotechnology • In Vitro • Drug Development • Pharmacokinetics • Infectious Diseases • Pharmaceutical Industry • Virology • Biomarker Discovery • Immunology • Biomarkers • Pharmacology • Cancer • Regulatory Affairs • Analytical Chemistry • Validation • Pharmaceutics • Lifesciences • Biology • Glp • Laboratory Skills • Antibody Drug Conjugates • Immuno Oncology • Genetically Engineered Mice

Ranks

Certificate:

Diplomate

Interests

Integration of Metabolism • Pathology • Lymphocyte Biology • Oncology • Pharmaceutics • Virology • Immuno Oncology • Antibody Drug Conjugates • Toxicology • Kinases • Signal Transduction • Biotransformation • Discovery Toxicology • See 9+See Less • Biomarker Discovery • Mechanistic Toxicology • Pharmacokinetics • Metabonomics

Industries

Pharmaceuticals

Resumes

Independent Consultant

view source

Location:

105 Decker Ct, Irving, TX 75062

Industry:

Pharmaceuticals

Work:

Bristol-Myers Squibb - Princeton, NJ since Sep 2003
Veterinary Pathology Fellow
Pharmacia 2001 - 2003
Research Advisor
Washington State University 1994 - 2001
Associate Professor, with tenure (previously, Assistant Professor)
Peace Corps - Ecuador Apr 1974 - Apr 1976
Volunteer

Education:

Washington State University 1993 - 1994
Postdoctoral, Dept of Biochemistry and Biophysics Washington State University 1988 - 1993
PhD, Veterinary Science University of Florida 1985 - 1988
Resident, Veterinary Anatomic Pathology Michigan State University 1977 - 1980
DVM, Veterinary Medicine University of Oxford 1973 - 1974
Cornell University 1970 - 1973
A.B., Biological Sciences Bloomfield Hills Andover High School 1967 - 1970

Skills:

Drug Discovery
Toxicology
Pathology
Biochemistry
Oncology
Life Sciences
Laboratory
Microbiology
In Vivo
Veterinary Medicine
Biotechnology
In Vitro
Drug Development
Pharmacokinetics
Infectious Diseases
Pharmaceutical Industry
Virology
Biomarker Discovery
Immunology
Biomarkers
Pharmacology
Cancer
Regulatory Affairs
Analytical Chemistry
Validation
Pharmaceutics
Lifesciences
Biology
Glp
Laboratory Skills
Antibody Drug Conjugates
Immuno Oncology
Genetically Engineered Mice

Interests:

Integration of Metabolism
Pathology
Lymphocyte Biology
Oncology
Pharmaceutics
Virology
Immuno Oncology
Antibody Drug Conjugates
Toxicology
Kinases
Signal Transduction
Biotransformation
Discovery Toxicology
See 9+See Less
Biomarker Discovery
Mechanistic Toxicology
Pharmacokinetics
Metabonomics

Certifications:

Diplomate

Name / Title

Company / Classification

Phones & Addresses

Glenn M. Cantor

ANNMITCH, LTD

Us Patents

Method Of Using Animal Models To Predict Adverse Drug Reactions
view source
US Patent:

20050005309, Jan 6, 2005
Filed:

Oct 20, 2003
Appl. No.:

10/689225
Inventors:

Glenn Cantor - Hopewell Township NJ, US
Martin Geppert - Ilford, GB
International Classification:

A01K067/027
US Classification:

800003000, 800014000
Abstract:

The invention relates generally to the process of target validation in the pharmaceutical industry. A process for validating molecular targets is disclosed.

Metabonomics Homogeneity Analysis
view source
US Patent:

20060210476, Sep 21, 2006
Filed:

Mar 6, 2006
Appl. No.:

11/368978
Inventors:

Glenn Cantor - Princeton NJ, US
Vikram Roongta - Belle Mead NJ, US
Nelly Aranibar - Lawrenceville NJ, US
Steven Bulera - Camillus NY, US
International Classification:

A61K 49/00
G06F 19/00
A61B 5/05
US Classification:

424009200, 702019000, 600412000
Abstract:

A metabonomic method of selecting one or more non-human primate subjects for inclusion in a study is disclosed. The method generally involves spectroscopically profiling a sample of bodily fluid acquired from a subject proposed to be included in the study. The subject is accepted or rejected as a member of the proposed study based on a chemometric analysis of the similarities and differences between the subjects' samples, which provides a homogeneous subject pool for the study. The method can be applied to any type of subject, for example, non-human primates.